These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11086288)

  • 1. Expression of calbindin D28K in the dopaminergic mesotelencephalic system in embryonic and fetal human brain.
    Verney C; Zecevic N; Ezan P
    J Comp Neurol; 2001 Jan; 429(1):45-58. PubMed ID: 11086288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of longitudinal brain zones that provide the origin for the substantia nigra and ventral tegmental area in human embryos, as revealed by cytoarchitecture and tyrosine hydroxylase, calretinin, calbindin, and GABA immunoreactions.
    Verney C; Zecevic N; Puelles L
    J Comp Neurol; 2001 Jan; 429(1):22-44. PubMed ID: 11086287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells.
    German DC; Manaye KF; Sonsalla PK; Brooks BA
    Ann N Y Acad Sci; 1992 May; 648():42-62. PubMed ID: 1353337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sparing of the dopaminergic neurons containing calbindin-D28k and of the dopaminergic mesocortical projections in weaver mutant mice.
    Gaspar P; Ben Jelloun N; Febvret A
    Neuroscience; 1994 Jul; 61(2):293-305. PubMed ID: 7969910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections.
    Thompson L; Barraud P; Andersson E; Kirik D; Björklund A
    J Neurosci; 2005 Jul; 25(27):6467-77. PubMed ID: 16000637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midbrain dopaminergic neurons in the mouse: co-localization with Calbindin-D28K and calretinin.
    Liang CL; Sinton CM; German DC
    Neuroscience; 1996 Nov; 75(2):523-33. PubMed ID: 8931015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K.
    Yamada T; McGeer PL; Baimbridge KG; McGeer EG
    Brain Res; 1990 Sep; 526(2):303-7. PubMed ID: 2257487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic neurons expressing calbindin in normal and parkinsonian monkeys.
    Lavoie B; Parent A
    Neuroreport; 1991 Oct; 2(10):601-4. PubMed ID: 1684519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient calbindin-D28k-positive systems in the telencephalon: ganglionic eminence, developing striatum and cerebral cortex.
    Liu FC; Graybiel AM
    J Neurosci; 1992 Feb; 12(2):674-90. PubMed ID: 1740695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease.
    Gibb WR
    Brain Res; 1992 May; 581(2):283-91. PubMed ID: 1382801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calretinin and calbindin-D28k in dopaminergic neurons of the rat midbrain: a triple-labeling immunohistochemical study.
    Nemoto C; Hida T; Arai R
    Brain Res; 1999 Oct; 846(1):129-36. PubMed ID: 10536220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of tyrosine hydroxylase-immunoreactive neurons in ventral mesencephalic tissue of Nurr1 deficient mice.
    Tornqvist N; Hermanson E; Perlmann T; Stromberg I
    Brain Res Dev Brain Res; 2002 Jan; 133(1):37-47. PubMed ID: 11850062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cytoarchitectonic and chemoarchitectonic analysis of the dopamine cell groups in the substantia nigra, ventral tegmental area, and retrorubral field in the mouse.
    Fu Y; Yuan Y; Halliday G; Rusznák Z; Watson C; Paxinos G
    Brain Struct Funct; 2012 Apr; 217(2):591-612. PubMed ID: 21935672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased susceptibility to oxidative stress underlies the resistance of specific dopaminergic cell populations to paraquat-induced degeneration.
    McCormack AL; Atienza JG; Langston JW; Di Monte DA
    Neuroscience; 2006 Aug; 141(2):929-937. PubMed ID: 16677770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axonal expression sites of tyrosine hydroxylase, calretinin- and calbindin-immunoreactivity in striato-pallidal and septal nuclei of the rat brain: a double-immunolabelling study.
    Seifert U; Härtig W; Grosche J; Brückner G; Riedel A; Brauer K
    Brain Res; 1998 Jun; 795(1-2):227-46. PubMed ID: 9622641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of the catecholaminergic neurons in the central nervous system of human embryos and fetuses.
    Verney C
    Microsc Res Tech; 1999 Jul; 46(1):24-47. PubMed ID: 10402270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the altered expression of tyrosine hydroxylase and calbindin-D 28kD immunoreactivities and viability of neurons in the ventral tegmental area of Tsai following injections of 6-hydroxydopamine in the medial forebrain bundle in the rat.
    Tan Y; Williams EA; Lancia AJ; Zahm DS
    Brain Res; 2000 Jun; 869(1-2):56-68. PubMed ID: 10865059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium-binding proteins typify the dopaminergic neuronal subtypes in the ventral tegmental area of zebra finch, Taeniopygia guttata.
    Mitra S; Basu S; Singh O; Srivastava A; Singru PS
    J Comp Neurol; 2022 Oct; 530(14):2562-2586. PubMed ID: 35715989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive effect of glial cell line-derived neurotrophic factor and neurotrophin-4/5 on rat fetal nigral explant cultures.
    Meyer M; Matarredona ER; Seiler RW; Zimmer J; Widmer HR
    Neuroscience; 2001; 108(2):273-84. PubMed ID: 11734360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease.
    Collier TJ; Sortwell CE; Elsworth JD; Taylor JR; Roth RH; Sladek JR; Redmond DE
    J Comp Neurol; 2002 Jan; 442(4):320-30. PubMed ID: 11793337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.